William E. Kennard - Jan 3, 2023 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anthony Lukaszewski, Authorized Signer
Stock symbol
MET
Transactions as of
Jan 3, 2023
Transactions value $
$37,518
Form type
4
Date filed
1/5/2023, 03:28 PM
Previous filing
Dec 16, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $37.5K +520 +1.54% $72.15 34.3K Jan 3, 2023 Direct F1
holding MET Common Stock 10 Jan 3, 2023 By the MetLife Policyholder Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
F2 Shares held in trust under the MetLife Policyholder Trust established to hold shares of Common Stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.